Four people recently died in Russia shortly after taking Sputnik V anti-corona stabbing in a previously unreported case. The European Union regulator, the European Medicines Agency (EMA) in Amsterdam, is taking these measures “seriously”.
The internal case file of RosPotrebNadzor, Russia’s vaccinating agency, showed that six other Russians also experienced medical complications after being vaccinated. Three of the dead were women aged 51, 69 and 74. The fourth place was not identified in the leaked documents. Russian documents show that the death is related to the heart, lungs or blood sugar, and may or may not be caused by Sputnik V.
Denis Logunov, a senior virologist at the Gamaleya Institute of Epidemiology and Microbiology in Moscow, officially confirmed the authenticity of one of the RosPotrebNadzor files, which developed SputnikV. He told EUobserver on Wednesday, April 7: “I asked for information about this case and got a reply. The case is not fake.”
The other six patients are young men and women, only 25 of them. They suffered from a series of symptoms, including difficulty breathing, convulsions, swelling, muscle weakness, high blood pressure, headache, dizziness and fever after fever. The Russian regional newspaper PLN Pskov reported one of the non-fatal cases.
Although Hungary has not yet obtained the EMA license, it has already begun to use Sputnik V. Austria, France, Germany and Italy are in advanced negotiations with Russia to purchase and co-produce the drug.
